Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends
XTalks
AUGUST 2, 2023
5) Ibrance (palbociclib) Ibrance is a chemotherapy drug indicated for hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. It also has a significant presence in consumer health sectors such as dermatology, nutritionals and allergy. billion in 2022. Astellas Pharma Inc.
Let's personalize your content